WHAT WE DO
We offer strategic support to companies during the drugs’ full lifecycle: from the regulatory process, including the Therapeutic Positioning Report (TPR) development to P&R submission, negotiation and approval, and Market Access at regional and hospital level. We do so by collaborating with relevant stakeholders, scientific societies and patients associations to ensure a successful Pricing and Market Access for innovative drugs in Spain.
OMAKASE LEADERSHIP TEAM
PUBLICATIONS
NEWS & EVENTS
-
Delighted to share an interesting debate, coordinated with Zogenix, about the Multiple Criteria Decision Analysis (MCDA) methodology as a new tool to empowerment of patients suffering from Dravet Syndrome.Delighted to share an interesting debate, coordinated with Zogenix, about the Multiple Criteria Decision Analysis (MCDA) methodology as a new tool to empowerment of patients suffering from Dravet Syndrome.
-
It has been a pleasure to coordinate, together with Zogenix, a project directed to provide information, training and contribute to empowerment of patients suffering from Dravet Syndrome and their caregiversIt has been a pleasure to coordinate, together with Zogenix, a project directed to provide information, training and contribute to empowerment of patients suffering from Dravet Syndrome and their caregivers
GET IN TOUCH
CONTACT INFO
BARCELONA & MADRID OFFICES
Telephone: +34 674614704 | +34 931890969
E-mail: administracion@omakaseconsulting.com
APPLY FOR A JOB
Please send your CV to: administracion@omakaseconsulting.com
Follow Us On Social Media!